Skip to content

Anti-B monoclonal (clone B2A22)

by Institut de Biotechnologies Jacques Boy France EUDAMED

Ref 152210263

EMDN W0103030101

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-03770008181588 Basic UDI-DIDate1 Jun 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Expiring (legacy directive)
  • Not covered

European Union — CE/IVDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 23 Oct 2026

Device Name
Anti-B monoclonal (clone B2A22)
Model / Reference
152210263
Primary DI / UDI-DI
03770008181588
Basic UDI-DI
B-03770008181588
EMDN Code
W0103030101 Abo grouping cells
Device Class
Class IVD Annex II List A
Market of Registration
France

Manufacturer details

EUDAMED SRN
FR-MF-000004609

Properties & raw data

Show properties, registry sources and raw records
  • Human Tissues
  • Reagent
  • Professional Testing
Other properties (7)
  • Sterile: No
  • Animal Tissues: No
  • Microbial Substances: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No

Sources (1)

  • EUDAMED 64d1fb65-8445-4e1e-8309-cf006a86e955 61 fields · synced 23 Oct 2026